Atlas Trials

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Clinical trial NCT07474103 · RECRUITING

Trial details

NCT number
NCT07474103
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Rectal Cancer, Adenocarcinoma
Start date
2025-11-30
Primary completion
2028-03-31
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.